======= C6 ======= == Gene Information == * **Official Symbol**: C6 * **Official Name**: complement C6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=729|729]] * **UniProt**: [[https://www.uniprot.org/uniprot/P13671|P13671]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/217050|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a component of the complement cascade. The encoded protein is part of the membrane attack complex that can be incorporated into the cell membrane and cause cell lysis. Mutations in this gene are associated with complement component-6 deficiency. Transcript variants encoding the same protein have been described.[provided by RefSeq, Nov 2012]. * **UniProt Summary**: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. |TSP 1| |Ldl recept a| |Sushi| |MACPF| |Kazal 2| |positive regulation of activation of membrane attack complex| |regulation of activation of membrane attack complex| |positive regulation of complement activation| |membrane attack complex| |positive regulation of humoral immune response| |cytolysis| |regulation of complement activation| |regulation of humoral immune response| |complement activation, classical pathway| |positive regulation of angiogenesis| |humoral immune response mediated by circulating immunoglobulin| |complement activation| |positive regulation of vasculature development| |immunoglobulin mediated immune response| |B cell mediated immunity| |positive regulation of immune effector process| |lymphocyte mediated immunity| |adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |regulation of angiogenesis| |regulation of vasculature development| |humoral immune response| |in utero embryonic development| |regulation of immune effector process| |adaptive immune response| |activation of immune response| |chordate embryonic development| |embryo development ending in birth or egg hatching| |innate immune response| |leukocyte mediated immunity| |positive regulation of immune response| |defense response to other organism| |embryo development| |regulation of anatomical structure morphogenesis| |immune effector process| |regulation of immune response| |positive regulation of immune system process| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |positive regulation of developmental process| |regulation of immune system process| |positive regulation of multicellular organismal process| |immune response| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp510|Nicotine 3000μM R08 exp510]]|1.71| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|2.06| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15512 * **Expression level (log2 read counts)**: -5.6 {{:chemogenomics:nalm6 dist.png?nolink |}}